Skip to main content

Table 2 Drug indication and the status of dose appropriateness of DOAC in the medical error reports

From: Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases

Drug indication DOAC type Statistical test* p
Apixaban (n = 134) Dabigatran (n = 28) Rivaroxaban (n = 37)
   Atrial fibrillation 73 (54.5%) 13 (46.4%) 27 (73.0%)   
Deep vein thrombosis 34 (25.4%) 13 (46.4%) 8 (21.6%)   
Cerebral venous thrombosis 2 (1.5%) 0 (0.0%) 0 (0.0%) 12.883 0.115
Pulmonary embolism 17 (12.7%) 1 (3.6%) 2 (5.4%)   
Others 8 (6.0%) 1 (3.6%) 0 (0.0%)   
  1. *Monte Carlo exact test: non-significant (p > 0.05)